Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies

BackgroundAutism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are childhood onset neurodevelopmental disorders that may persist into adulthood. ASD and ADHD tend to run in families and may have a significant negative impact on the health and longevity of those with the disorder and their relatives. The aim of this study will be to analyze the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives.Methods/designWe will conduct a systematic review and meta-analysis of observational studies. Searches of PubMed/MEDLINE, EMBASE, PsycINFO, SCOPUS, and ISI Web of Science will be used to identify epidemiological studies. Eligible studies will be observational studies reporting study-specific data for all-cause mortality or cause-specific mortality in children, adolescents, or adults with ASD or ADHD and/or their first-degree relatives. Cohort studies and case-control studies will be included. The primary outcome will be all-cause mortality. The secondary outcome will be cause-specific mortality. Two reviewers will independently screen references identified by the literature search, as well as potentially relevant full-text articles. Data will be abstracted, and study risk of bias/methodological quality will be appraised by two reviewers independently. The methodological quality of epidemiological studies will be appraised using the Newcastle-Ottawa Scale (NOS). Conflicts at all levels of screening and abstraction will be resolved through discussion. Random-effects meta-analyses of primary studies will be conducted where appropriate. Subgroup analyses for exploring statistical heterogeneity, if feasible, will include gender, age group, ethnicity, comorbidities, classification of cause of death, and relevant study characteristics.DiscussionOur study will establish the extent of the epidemiological evidence underlying the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. We anticipate that our findings will be of interest to patients, their families, caregivers, healthcare professionals, scientists, and policy makers. Implications for future epidemiological research will be discussed.Systematic review registrationPROSPERO CRD42017059955.

[1]  Ceri H. Davies,et al.  Neurodevelopmental disorders , 2013, Neuropharmacology.

[2]  H. Leonard,et al.  Early Mortality and Primary Causes of Death in Mothers of Children with Intellectual Disability or Autism Spectrum Disorder: A Retrospective Cohort Study , 2014, PloS one.

[3]  S. Bölte,et al.  Premature mortality in autism spectrum disorder , 2016, British Journal of Psychiatry.

[4]  M. Coory,et al.  A systematic review of two outcomes in autism spectrum disorder – epilepsy and mortality , 2012, Developmental medicine and child neurology.

[5]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[6]  Ashutosh Kumar Singh,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[7]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[8]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[9]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[10]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[11]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[12]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[13]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[14]  P. Westwood.  Intellectual Disability and Autism , 2008 .

[15]  C. Lord.  Infant autism: parents' role in ameliorating risk? , 2015, The lancet. Psychiatry.

[16]  Ashutosh Kumar Singh,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[17]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[18]  Eric P Hoffman,et al.  Genomics , Intellectual Disability , and Autism , 2012 .

[19]  M. Page,et al.  Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies , 2017, Systematic Reviews.

[20]  F. Catalá-López,et al.  Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies , 2017, Systematic Reviews.

[21]  R. Atun,et al.  Estimating the true global burden of mental illness. , 2016, The lancet. Psychiatry.

[22]  M. Harrison.  A Global Perspective , 2015, Bulletin of the history of medicine.

[23]  G. Dunn,et al.  Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study , 2001, The Lancet.

[24]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[25]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[26]  Dan J Stein,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.

[27]  Stephen J. Gentles,et al.  The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. , 2013, Journal of clinical epidemiology.

[28]  M. Goldacre,et al.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006 , 2011, BMJ : British Medical Journal.

[29]  T. Vos,et al.  Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010 , 2014, Epidemiology and Psychiatric Sciences.

[30]  N. Ekas,et al.  Death concerns and psychological well-being in mothers of children with autism spectrum disorder. , 2015, Research in developmental disabilities.

[31]  S. Dalsgaard,et al.  Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study , 2015, The Lancet.

[32]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[33]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[34]  Dan J Stein,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.

[35]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[36]  M. Overgaard,et al.  Association of Psychiatric and Neurologic Comorbidity With Mortality Among Persons With Autism Spectrum Disorder in a Danish Population. , 2016, JAMA pediatrics.

[37]  Jonathan A C Sterne,et al.  Meta-Analysis in Stata: An Updated Collection from the Stata Journal , 2015 .

[38]  S. Faraone.  Attention deficit hyperactivity disorder and premature death , 2015, The Lancet.

[39]  T. Vos,et al.  Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010 – CORRIGENDUM , 2015, Epidemiology and Psychiatric Sciences.

[40]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2015, BMJ : British Medical Journal.

[41]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[42]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[43]  J. Ioannidis,et al.  Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[45]  R. Stewart,et al.  Ethnicity and excess mortality in severe mental illness: a cohort study , 2017, The lancet. Psychiatry.

[46]  B. Druss,et al.  Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. , 2015, JAMA psychiatry.

[47]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.